DocGo Inc. (NASDAQ:DCGO) Given Average Recommendation of “Hold” by Brokerages

DocGo Inc. (NASDAQ:DCGO) has earned an average recommendation of “Hold” from the six brokerages that are presently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and three have assigned a buy rating to the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $2.3750.

DCGO has been the subject of several research reports. Needham & Company LLC reiterated a “buy” rating and issued a $3.00 target price on shares of DocGo in a research note on Tuesday, March 17th. Cantor Fitzgerald reiterated an “overweight” rating on shares of DocGo in a research note on Monday, May 11th. Canaccord Genuity Group reduced their target price on shares of DocGo from $1.50 to $1.00 and set a “hold” rating for the company in a research note on Wednesday, March 25th. Stifel Nicolaus dropped their price target on shares of DocGo from $4.00 to $2.50 and set a “buy” rating for the company in a research report on Tuesday, March 17th. Finally, Wall Street Zen raised shares of DocGo from a “sell” rating to a “hold” rating in a research report on Saturday, May 16th.

DocGo Price Performance

DCGO stock opened at $0.63 on Friday. DocGo has a 52-week low of $0.49 and a 52-week high of $1.78. The company has a 50-day moving average of $0.62 and a two-hundred day moving average of $0.79. The stock has a market capitalization of $62.26 million, a price-to-earnings ratio of -0.33 and a beta of 1.02.

DocGo (NASDAQ:DCGO) last released its earnings results on Monday, May 11th. The company reported ($0.12) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($0.10). DocGo had a negative net margin of 62.23% and a negative return on equity of 44.09%. The company had revenue of $75.55 million during the quarter, compared to the consensus estimate of $72.48 million. Equities analysts expect that DocGo will post -0.12 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in DCGO. Renaissance Technologies LLC raised its position in DocGo by 167.1% in the first quarter. Renaissance Technologies LLC now owns 1,510,361 shares of the company’s stock worth $950,000 after purchasing an additional 944,826 shares in the last quarter. Millennium Management LLC raised its position in DocGo by 878.6% in the third quarter. Millennium Management LLC now owns 766,210 shares of the company’s stock worth $1,042,000 after purchasing an additional 687,911 shares in the last quarter. Goldman Sachs Group Inc. raised its position in DocGo by 205.4% in the fourth quarter. Goldman Sachs Group Inc. now owns 805,427 shares of the company’s stock worth $707,000 after purchasing an additional 541,670 shares in the last quarter. AQR Capital Management LLC increased its holdings in shares of DocGo by 219.1% during the first quarter. AQR Capital Management LLC now owns 476,645 shares of the company’s stock worth $1,258,000 after buying an additional 327,269 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its holdings in shares of DocGo by 92.0% during the third quarter. JPMorgan Chase & Co. now owns 557,613 shares of the company’s stock worth $758,000 after buying an additional 267,259 shares in the last quarter. Institutional investors and hedge funds own 56.44% of the company’s stock.

DocGo Company Profile

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.